| Entry |
|
| Name |
EBV EBNA1 to p53-mediated transcription
|
| Definition |
EBNA1 -| USP7 -> TP53 => (CDKN1A,GADD45,BAX,BAK1,DDB2,POLK) |
| Expanded |
K19461 -| 7874 -> 7157 => (1026,1647,4616,10912,581,578,1643,51426) |
| Class |
|
| Type |
Pathogen
|
| Pathway |
|
| Disease |
|
| Gene |
| 7874 | USP7; ubiquitin specific peptidase 7 |
| 7157 | TP53; tumor protein p53 |
| 1026 | CDKN1A; cyclin dependent kinase inhibitor 1A |
| 1647 | GADD45A; growth arrest and DNA damage inducible alpha |
| 4616 | GADD45B; growth arrest and DNA damage inducible beta |
| 10912 | GADD45G; growth arrest and DNA damage inducible gamma |
| 581 | BAX; BCL2 associated X, apoptosis regulator |
| 578 | BAK1; BCL2 antagonist/killer 1 |
| 1643 | DDB2; damage specific DNA binding protein 2 |
| 51426 | POLK; DNA polymerase kappa |
|
| Perturbant |
| K19461 (EBNA1) | EBNA1; EBV nuclear antigen 1 |
|
| Reference |
|
| Authors |
Saha A, Robertson ES |
| Title |
Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes. |
| Journal |
|
| Reference |
|
| Authors |
Holowaty MN, Sheng Y, Nguyen T, Arrowsmith C, Frappier L |
| Title |
Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP. |
| Journal |
|
| Reference |
|
| Authors |
Kang H, Kiess A, Chung CH |
| Title |
Emerging biomarkers in head and neck cancer in the era of genomics. |
| Journal |
|
| Reference |
|
| Authors |
Tornesello ML, Annunziata C, Tornesello AL, Buonaguro L, Buonaguro FM |
| Title |
Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers. |
| Journal |
|
| Reference |
|
| Authors |
Yi F, Saha A, Murakami M, Kumar P, Knight JS, Cai Q, Choudhuri T, Robertson ES |
| Title |
Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities. |
| Journal |
|
| LinkDB |
|